IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $197,905,000 | +68.8% | 2,327,474 | -29.6% | 0.16% | +50.0% |
Q2 2020 | $117,209,000 | +65.0% | 3,307,240 | -37.3% | 0.11% | +23.3% |
Q1 2020 | $71,057,000 | +11.1% | 5,271,294 | +74.3% | 0.09% | +32.3% |
Q4 2019 | $63,979,000 | +75.3% | 3,023,577 | +9.9% | 0.06% | +66.7% |
Q3 2019 | $36,491,000 | -12.6% | 2,751,940 | -8.6% | 0.04% | -4.9% |
Q2 2019 | $41,738,000 | -28.6% | 3,009,238 | -1.1% | 0.04% | -29.3% |
Q1 2019 | $58,426,000 | +65.7% | 3,041,417 | +23.1% | 0.06% | +48.7% |
Q4 2018 | $35,267,000 | -21.7% | 2,471,401 | +14.3% | 0.04% | -4.9% |
Q3 2018 | $45,024,000 | -11.3% | 2,161,515 | +0.7% | 0.04% | -18.0% |
Q2 2018 | $50,785,000 | +64.7% | 2,145,563 | +1.7% | 0.05% | +61.3% |
Q1 2018 | $30,833,000 | +4.2% | 2,110,377 | +15.3% | 0.03% | +6.9% |
Q4 2017 | $29,588,000 | +16.8% | 1,830,914 | +1.1% | 0.03% | +11.5% |
Q3 2017 | $25,328,000 | +164.4% | 1,811,719 | +67.0% | 0.03% | +160.0% |
Q2 2017 | $9,581,000 | – | 1,084,996 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |